Segal, Neil Howard

Publications

Sort by

Co-Author Network

selected publications

Clinical implications of drug-induced liver injury in early-phase oncology clinical trials. Cancer. 2020 Academic Article GET IT
Times cited: 4
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA oncology. 2019 Academic Article GET IT
Times cited: 270
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort. European journal of cancer (Oxford, England : 1990). 2019 Academic Article GET IT
Times cited: 58
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 290
Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 132
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy. Ophthalmology. 2017 Academic Article GET IT
Times cited: 80
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 58
Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2016 Academic Article GET IT
Times cited: 36
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 230
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 703
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 121
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 678
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/min. Journal of oncology practice. 2016 Academic Article GET IT
Times cited: 4
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. European journal of cancer (Oxford, England : 1990). 2016 Review GET IT
Times cited: 287
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 175
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1. 2016 GET IT
Times cited: 217
A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer. Clinical colorectal cancer. 2016 Academic Article GET IT
Times cited: 28
Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers. Oncology (Williston Park, N.Y.). 2016 Review GET IT
Times cited: 3
Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis. Nutrition and cancer. 2015 Academic Article GET IT
Times cited: 39
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. Journal of the National Cancer Institute. 2014 Academic Article GET IT
Times cited: 165
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 70
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 149
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. British journal of cancer. 2013 Academic Article GET IT
Times cited: 99
Nivolumab plus ipilimumab in advanced melanoma. The New England journal of medicine. 2013 Academic Article GET IT
Times cited: 3352
A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients. Journal of palliative medicine. 2013 Academic Article GET IT
Times cited: 71
Valgus malalignment is a risk factor for lateral knee osteoarthritis incidence and progression: findings from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative. Arthritis and rheumatism. 2013 Academic Article GET IT
Times cited: 190
Management of a locally advanced rectal cancer in a patient who declined surgery. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
The role of varus and valgus alignment in the initial development of knee cartilage damage by MRI: the MOST study. Annals of the rheumatic diseases. 2012 Academic Article GET IT
Times cited: 143
Antitumor activity in metastatic disease does not predict efficacy in the adjuvant setting. JAMA. 2012 Editorial Article GET IT
Times cited: 3
Varus and valgus alignment and incident and progressive knee osteoarthritis. Annals of the rheumatic diseases. 2010 Academic Article GET IT
Times cited: 294
Evolving treatment of advanced colon cancer. Annual review of medicine. 2009 Review GET IT
Times cited: 110
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proceedings of the National Academy of Sciences of the United States of America. 2008 Academic Article GET IT
Times cited: 293
Is adjuvant therapy for stage II colon cancer worthwhile, and for whom?. Nature clinical practice. Gastroenterology & hepatology. 2008 Comment GET IT
Times cited: 5
Epitope landscape in breast and colorectal cancer. Cancer research. 2008 Academic Article GET IT
Times cited: 339
Targeting immunosupportive cancer therapies: accentuate the positive, eliminate the negative. Cancer cell. 2007 Academic Article GET IT
Times cited: 56
Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression. The Journal of surgical research. 2006 Academic Article GET IT
Times cited: 58
EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation. 2006 GET IT
Times cited: 261
Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer research. 2005 Academic Article GET IT
Times cited: 126
Antigens recognized by autologous antibodies of patients with soft tissue sarcoma. Cancer immunity. 2005 Academic Article GET IT
Times cited: 11
Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics. Cancer immunity. 2005 Academic Article GET IT
Times cited: 35
Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2004 Academic Article GET IT
Times cited: 78
Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 190
Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. The American journal of pathology. 2003 Academic Article GET IT
Times cited: 195
Cross-presentation of disialoganglioside GD3 to natural killer T cells. The Journal of experimental medicine. 2003 Academic Article GET IT
Times cited: 243
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 165
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
Times cited: 293
The role of lipopolysaccharide in T-cell responses following DNA vaccination. Vaccine. 2003 Academic Article GET IT
Times cited: 7
BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell. Archives of pathology & laboratory medicine. 1994 Academic Article GET IT
Times cited: 70

more ...

less ...

Background

education and training

Ph.D., University of Witwatersrand (South Africa) 1998
M.D., University of Witwatersrand Faculty of Health Sciences (South Africa) 1996
B.Sc., University of Witwatersrand (South Africa) 1991
B.Sc., University of Witwatersrand (South Africa) 1990

Contact

full name

Neil Howard Segal

VIVO Weill Cornell Medical College

Neil Howard Segal Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name